MRKR

$0.00

(

0.00%

)
Quote details

stock

Marker Therapeutics Inc

NASDAQ | MRKR

0.94

USD

$0.00

(

0.00%

)

At Close (As of Sep 15, 2025)

$12.35M

Market Cap

-

P/E Ratio

-1.34

EPS

$5.95

52 Week High

$0.81

52 Week Low

HEALTHCARE

Sector

MRKR Chart

Recent Chart
Price Action

MRKR Technicals

Tags:

MRKR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$6.9M
Total Revenue $6.6M
Cost Of Revenue $13M
Costof Goods And Services Sold $13M
Operating Income -$11M
Selling General And Administrative $4.2M
Research And Development $13M
Operating Expenses $18M
Investment Income Net -
Net Interest Income $437K
Interest Income $437K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$6.2M
Income Before Tax -$11M
Income Tax Expense $50K
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.5M
Net Income -$11M

Revenue & Profitability

Earnings Performance

MRKR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $22M
Total Current Assets $22M
Cash And Cash Equivalents At Carrying Value $19M
Cash And Short Term Investments $19M
Inventory -
Current Net Receivables $2.3M
Total Non Current Assets $0
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $19T
Other Current Assets $484K
Other Non Current Assets -
Total Liabilities $3.5M
Total Current Liabilities $3.5M
Current Accounts Payable $1.1M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $2.3M
Other Non Current Liabilities -
Total Shareholder Equity $19M
Treasury Stock -
Retained Earnings -$447M
Common Stock $11K
Common Stock Shares Outstanding $9M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$11M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $15M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$11M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$6.9M
Total Revenue $6.6M
Cost Of Revenue $13M
Costof Goods And Services Sold $13M
Operating Income -$11M
Selling General And Administrative $4.2M
Research And Development $13M
Operating Expenses $18M
Investment Income Net -
Net Interest Income $437K
Interest Income $437K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -$6.2M
Income Before Tax -$11M
Income Tax Expense $50K
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$4.5M
Ebitda -$4.5M
Net Income -$11M

MRKR News

MRKR Profile

Marker Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas.

ADAP
+20.12%
$0.08
CODX
+80.75%
$0.63
CGBS
-39.47%
$0.03
MULN
+9.26%
$0.07
TURB
+359.25%
$12.40
BITF
+15.32%
$2.86
NVDA
-1.61%
$174.88
SNAP
+3.11%
$7.69
NIO
+8.24%
$7.02
APVO
+4.16%
$1.50
MARA
+7.94%
$17.53
KDLY
-55.39%
$1.24
GRAB
+2.85%
$6.31
AAL
-0.95%
$12.41
TSLA
+3.15%
$422.99
OPI
-5.54%
$0.83
WBD
-6.19%
$18.25
NAKA
+18.95%
$1.47
TPIC
-45.91%
$0.12
PLUG
+7.00%
$1.68
DNN
-2.92%
$2.50
AXDX
-61.36%
$0.03
SOFI
-0.90%
$27.42
SOUN
+3.52%
$14.69
SLNH
+3.79%
$0.96
AAPL
+0.61%
$238.15
NFE
+44.92%
$2.00
RIVN
+5.29%
$14.32
F
-0.59%
$11.61
JOBY
+1.77%
$14.37
NAOV
+64.86%
$10.70
LYT
-16.77%
$0.09
RIOT
+5.03%
$17.52
BMNR
+5.31%
$55.93
CJET
+0.43%
$0.11
RR
-0.51%
$3.87
BTG
-1.48%
$4.32
PFE
-0.39%
$23.87
BGI
+58.97%
$1.35
INTC
+2.13%
$25.30
BINI
-15.62%
$0.06
ORCL
+1.30%
$306.07
ATYR
+6.40%
$1.08
RAYA
-1.47%
$0.04
ATCH
-13.06%
$0.86
RGTI
+4.11%
$20.00
BOXL
+45.66%
$2.52
ABEV
+1.50%
$2.36
QS
-2.17%
$10.13
CNFR
+55.53%
$1.76
HIMS
-5.35%
$51.07
RKLB
-12.64%
$47.20
RMBL
+60.50%
$3.21
BBD
+0.78%
$3.20
DVLT
+32.99%
$0.44
ADD
-25.47%
$0.05
AMZN
+1.13%
$234.05
TLRY
+3.38%
$1.22
VALE
+0.87%
$10.92
ONDS
-4.54%
$6.09
WULF
-2.50%
$10.49
HOOD
+2.22%
$117.38
IREN
-1.85%
$36.45
SRM
+53.27%
$10.30
QBTS
+3.68%
$18.99
KEY
-1.14%
$18.62
GOOGL
-0.17%
$251.16
ITUB
+0.21%
$7.15
LPSN
-22.92%
$0.68
CAN
-1.22%
$0.80
BAC
+0.19%
$50.69
NOK
+1.20%
$4.60
IONQ
+5.31%
$62.25
BTE
-0.15%
$2.36
NWTN
+3.42%
$1.51
AIIO
+3.42%
$1.51
PLTR
-0.49%
$170.36
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CLSK
+8.84%
$11.20
ORIS
-23.42%
$0.13
QUBT
+0.20%
$16.87
CRWV
-1.42%
$118.75
WLGS
-5.57%
$0.04
FAAS
-23.86%
$0.09
CIFR
+6.40%
$11.54
RZLV
-0.79%
$7.65
AMD
-0.43%
$160.46
RIG
+4.98%
$3.47
ACHR
-0.53%
$9.07
ETWO
0.00%
$3.30
OSCR
-4.40%
$17.90
CVE
+2.65%
$17.61
HBAN
-1.13%
$17.43
BURU
-8.18%
$0.13
JD
+3.15%
$34.68
LYFT
-1.22%
$20.19
AMCR
+1.50%
$8.40
BABA
+2.68%
$162.29
GOOG
-0.13%
$251.42
ADAP
+20.12%
$0.08
CODX
+80.75%
$0.63
CGBS
-39.47%
$0.03
MULN
+9.26%
$0.07
TURB
+359.25%
$12.40
BITF
+15.32%
$2.86
NVDA
-1.61%
$174.88
SNAP
+3.11%
$7.69
NIO
+8.24%
$7.02
APVO
+4.16%
$1.50
MARA
+7.94%
$17.53
KDLY
-55.39%
$1.24
GRAB
+2.85%
$6.31
AAL
-0.95%
$12.41
TSLA
+3.15%
$422.99
OPI
-5.54%
$0.83
WBD
-6.19%
$18.25
NAKA
+18.95%
$1.47
TPIC
-45.91%
$0.12
PLUG
+7.00%
$1.68
DNN
-2.92%
$2.50
AXDX
-61.36%
$0.03
SOFI
-0.90%
$27.42
SOUN
+3.52%
$14.69
SLNH
+3.79%
$0.96
AAPL
+0.61%
$238.15
NFE
+44.92%
$2.00
RIVN
+5.29%
$14.32
F
-0.59%
$11.61
JOBY
+1.77%
$14.37
NAOV
+64.86%
$10.70
LYT
-16.77%
$0.09
RIOT
+5.03%
$17.52
BMNR
+5.31%
$55.93
CJET
+0.43%
$0.11
RR
-0.51%
$3.87
BTG
-1.48%
$4.32
PFE
-0.39%
$23.87
BGI
+58.97%
$1.35
INTC
+2.13%
$25.30
BINI
-15.62%
$0.06
ORCL
+1.30%
$306.07
ATYR
+6.40%
$1.08
RAYA
-1.47%
$0.04
ATCH
-13.06%
$0.86
RGTI
+4.11%
$20.00
BOXL
+45.66%
$2.52
ABEV
+1.50%
$2.36
QS
-2.17%
$10.13
CNFR
+55.53%
$1.76
HIMS
-5.35%
$51.07
RKLB
-12.64%
$47.20
RMBL
+60.50%
$3.21
BBD
+0.78%
$3.20
DVLT
+32.99%
$0.44
ADD
-25.47%
$0.05
AMZN
+1.13%
$234.05
TLRY
+3.38%
$1.22
VALE
+0.87%
$10.92
ONDS
-4.54%
$6.09
WULF
-2.50%
$10.49
HOOD
+2.22%
$117.38
IREN
-1.85%
$36.45
SRM
+53.27%
$10.30
QBTS
+3.68%
$18.99
KEY
-1.14%
$18.62
GOOGL
-0.17%
$251.16
ITUB
+0.21%
$7.15
LPSN
-22.92%
$0.68
CAN
-1.22%
$0.80
BAC
+0.19%
$50.69
NOK
+1.20%
$4.60
IONQ
+5.31%
$62.25
BTE
-0.15%
$2.36
NWTN
+3.42%
$1.51
AIIO
+3.42%
$1.51
PLTR
-0.49%
$170.36
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CLSK
+8.84%
$11.20
ORIS
-23.42%
$0.13
QUBT
+0.20%
$16.87
CRWV
-1.42%
$118.75
WLGS
-5.57%
$0.04
FAAS
-23.86%
$0.09
CIFR
+6.40%
$11.54
RZLV
-0.79%
$7.65
AMD
-0.43%
$160.46
RIG
+4.98%
$3.47
ACHR
-0.53%
$9.07
ETWO
0.00%
$3.30
OSCR
-4.40%
$17.90
CVE
+2.65%
$17.61
HBAN
-1.13%
$17.43
BURU
-8.18%
$0.13
JD
+3.15%
$34.68
LYFT
-1.22%
$20.19
AMCR
+1.50%
$8.40
BABA
+2.68%
$162.29
GOOG
-0.13%
$251.42

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.